-1.59 (-4.994%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Anbio Biotechnology Class A
Telephone
49.69.870039170
Address
Wilhelm Gutbrod Street, 21B, Frankfurt, Hessen 60437
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 7.23 - 55.65
Trade Value (12mth)
US$551,648.00
1 week
18.19%
1 month
11.99%
YTD
8.01%
1 year
310.84%
All time high
55.65
EPS 3 yr Growth
-33.80%
EBITDA Margin
66.70%
Operating Cashflow
-$8m
Free Cash Flow Return
-28.60%
ROIC
27.20%
Interest Coverage
0.00
Quick Ratio
344.30
Shares Outstanding (Fully Diluted)
44m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 19 May 26 | |
| 28 April 26 | |
| 09 April 26 | |
| 08 April 26 | |
| 18 February 26 |
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | US$ |  | | | | 0.06 | 0.06 | 0.16 | | | | ||
EPS (Fully Diluted) | US$ | | | | | 0.06 | 0.06 | 0.16 | | | | ||
Growth | % | | | | | -76.8 | 5.4 | 171.2 | | | | ||
PE | X | | | | | N/A | N/A | 182.7 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 200.6 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
